<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>clozapine</title><link>http://www.unboundmedicine.com/medline/ebm/research/clozapine</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl Clozapine (Norclozapine) in human serum.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19927349/full_citation/Rapid_liquid_chromatography/tandem_mass_spectrometer__LCMS__method_for_clozapine_and_its_metabolite_N_desmethyl_Clozapine__Norclozapine__in_human_serum_</link><description>Rao LV, Snyder ML, Vallaro GM <br/><span class="title">Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl Clozapine (Norclozapine) in human serum. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of clinical laboratory analysis">J Clin Lab Anal 2009 Nov 19; 23(6):394-398.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19927349/abstract/Rapid_liquid_chromatography/tandem_mass_spectrometer__LCMS__method_for_clozapine_and_its_metabolite_N_desmethyl_Clozapine__Norclozapine__in_human_serum_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19927349/full_citation/Rapid_liquid_chromatography/tandem_mass_spectrometer__LCMS__method_for_clozapine_and_its_metabolite_N_desmethyl_Clozapine__Norclozapine__in_human_serum_">Full Citation</a></description></item><item><title>Treatment of Refractory Hypotension With Low-Dose Vasopressin in a Patient Receiving Clozapine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926306/full_citation/Treatment_of_Refractory_Hypotension_With_Low_Dose_Vasopressin_in_a_Patient_Receiving_Clozapine_</link><description>John A, Yeh C, Boyd J, et al. <br/><span class="title">Treatment of Refractory Hypotension With Low-Dose Vasopressin in a Patient Receiving Clozapine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of cardiothoracic and vascular anesthesia">J Cardiothorac Vasc Anesth 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926306/full_citation/Treatment_of_Refractory_Hypotension_With_Low_Dose_Vasopressin_in_a_Patient_Receiving_Clozapine_">Full Citation</a></description></item><item><title>The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922755/full_citation/The_role_of_histaminergic_H1_and_H3_receptors_in_food_intake:_A_mechanism_for_atypical_antipsychotic_induced_weight_gain</link><description>Deng C, Weston-Green K, Huang XF <br/><span class="title">The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain? [JOURNAL ARTICLE]</span><br/><span class="source" title="Progress in neuro-psychopharmacology &amp; biological psychiatry">Prog Neuropsychopharmacol Biol Psychiatry 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922755/abstract/The_role_of_histaminergic_H1_and_H3_receptors_in_food_intake:_A_mechanism_for_atypical_antipsychotic_induced_weight_gain">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922755/full_citation/The_role_of_histaminergic_H1_and_H3_receptors_in_food_intake:_A_mechanism_for_atypical_antipsychotic_induced_weight_gain">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922755/The_role_of_histaminergic_H1_and_H3_receptors_in_food_intake:_A_mechanism_for_atypical_antipsychotic_induced_weight_gain">Find Related Articles</a> </description></item><item><title>[Acute hepatocellular lesion after successive exposure to clozapine and olanzapine in a patient with chronic hepatitis C infection.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19914745/full_citation/[Acute_hepatocellular_lesion_after_successive_exposure_to_clozapine_and_olanzapine_in_a_patient_with_chronic_hepatitis_C_infection_]</link><description>Gómez Espín R, Sánchez Quiles I, Hallal H, et al. <br/><span class="title">[Acute hepatocellular lesion after successive exposure to clozapine and olanzapine in a patient with chronic hepatitis C infection.] [LETTER]</span><br/><span class="source" title="Gastroenterologia y hepatologia">Gastroenterol Hepatol 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19914745/full_citation/[Acute_hepatocellular_lesion_after_successive_exposure_to_clozapine_and_olanzapine_in_a_patient_with_chronic_hepatitis_C_infection_]">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19914745/[Acute_hepatocellular_lesion_after_successive_exposure_to_clozapine_and_olanzapine_in_a_patient_with_chronic_hepatitis_C_infection_]">Find Related Articles</a> </description></item><item><title>Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19913390/full_citation/Effects_of_clozapine_and_olanzapine_on_cortical_thickness_in_childhood_onset_schizophrenia_</link><description>Mattai A, Chavez A, Greenstein D, et al. <br/><span class="title">Effects of clozapine and olanzapine on cortical thickness in childhood-onset schizophrenia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Schizophrenia research">Schizophr Res 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19913390/abstract/Effects_of_clozapine_and_olanzapine_on_cortical_thickness_in_childhood_onset_schizophrenia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19913390/full_citation/Effects_of_clozapine_and_olanzapine_on_cortical_thickness_in_childhood_onset_schizophrenia_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19913390/Effects_of_clozapine_and_olanzapine_on_cortical_thickness_in_childhood_onset_schizophrenia_">Find Related Articles</a> </description></item><item><title>Management of clozapine-related hepatotoxicity.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19910731/full_citation/Management_of_clozapine_related_hepatotoxicity_</link><description>Keane S, Lane A, Larkin T, et al. <br/><span class="title">Management of clozapine-related hepatotoxicity. [Letter]</span><br/><span class="source" title="Journal of clinical psychopharmacology">J Clin Psychopharmacol 2009 Dec; 29(6):606-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19910731/full_citation/Management_of_clozapine_related_hepatotoxicity_">Full Citation</a> | <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm%3fissn=0271-0749%26amp;volume=29%26amp;issue=6%26amp;spage=606">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19910731/Management_of_clozapine_related_hepatotoxicity_">Find Related Articles</a> </description></item><item><title>Strategies to Enhance N-Methyl-D-aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909229/full_citation/Strategies_to_Enhance_N_Methyl_D_aspartate_Receptor_Mediated_Neurotransmission_in_Schizophrenia_a_Critical_Review_and_Meta_Analysis_</link><description>Tsai GE, Lin PY <br/><span class="title">Strategies to Enhance N-Methyl-D-aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current pharmaceutical design">Curr Pharm Des 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909229/abstract/Strategies_to_Enhance_N_Methyl_D_aspartate_Receptor_Mediated_Neurotransmission_in_Schizophrenia_a_Critical_Review_and_Meta_Analysis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909229/full_citation/Strategies_to_Enhance_N_Methyl_D_aspartate_Receptor_Mediated_Neurotransmission_in_Schizophrenia_a_Critical_Review_and_Meta_Analysis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19909229/Strategies_to_Enhance_N_Methyl_D_aspartate_Receptor_Mediated_Neurotransmission_in_Schizophrenia_a_Critical_Review_and_Meta_Analysis_">Find Related Articles</a> </description></item><item><title>Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909228/full_citation/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_</link><description>López-Gil X, Artigas F, Adell A <br/><span class="title">Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex. [JOURNAL ARTICLE]</span><br/><span class="source" title="Current pharmaceutical design">Curr Pharm Des 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909228/abstract/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909228/full_citation/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19909228/Unraveling_Monoamine_Receptors_Involved_in_the_Action_of_Typical_and_Atypical_Antipsychotics_on_Glutamatergic_and_Serotonergic_Transmission_in_Prefrontal_Cortex_">Find Related Articles</a> </description></item><item><title>Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19909227/full_citation/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity</link><description>Mailman RB, Murthy V <br/><span class="title">Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity? [JOURNAL ARTICLE]</span><br/><span class="source" title="Current pharmaceutical design">Curr Pharm Des 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19909227/abstract/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19909227/full_citation/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19909227/Third_Generation_Antipsychotic_Drugs:_Partial_Agonism_or_Receptor_Functional_Selectivity">Find Related Articles</a> </description></item><item><title>Pimavanserin, a Serotonin(2A) Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19907417/full_citation/Pimavanserin_a_Serotonin_2A__Receptor_Inverse_Agonist_for_the_Treatment_of_Parkinson's_Disease_Psychosis_</link><description>Meltzer HY, Mills R, Revell S, et al. <br/><span class="title">Pimavanserin, a Serotonin(2A) Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology">Neuropsychopharmacology 2009 Nov 11.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19907417/abstract/Pimavanserin_a_Serotonin_2A__Receptor_Inverse_Agonist_for_the_Treatment_of_Parkinson's_Disease_Psychosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19907417/full_citation/Pimavanserin_a_Serotonin_2A__Receptor_Inverse_Agonist_for_the_Treatment_of_Parkinson's_Disease_Psychosis_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19907417/Pimavanserin_a_Serotonin_2A__Receptor_Inverse_Agonist_for_the_Treatment_of_Parkinson's_Disease_Psychosis_">Find Related Articles</a> </description></item></channel></rss>